Abstract
BackgroundHigh dose IL-2 treatment in metastatic renal cell carcinoma and metastatic melanoma patients induced complete remission in 5%–10% of patients without recurrence for over 25 years and potentially cured 70%...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have